These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 10795650)

  • 21. The efficacy and safety of mometasone furoate delivered via a dry powder inhaler for the treatment of asthma.
    Meltzer EO; Wenzel S
    J Asthma; 2006 Dec; 43(10):765-72. PubMed ID: 17169829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy, safety, and tolerability of mometasone furoate in adult Japanese patients with mild asthma: open-label clinical trial findings.
    Tohda Y; Miyamoto T
    Curr Med Res Opin; 2010 Jan; 26(1):203-12. PubMed ID: 19921960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-ranging study of a new steroid for asthma: mometasone furoate dry powder inhaler.
    Bernstein DI; Berkowitz RB; Chervinsky P; Dvorin DJ; Finn AF; Gross GN; Karetzky M; Kemp JP; Laforce C; Lumry W; Mendelson LM; Nelson H; Pearlman D; Rachelefsky G; Ratner P; Repsher L; Segal AT; Selner JC; Settipane GA; Wanderer A; Cuss FM; Nolop KB; Harrison JE
    Respir Med; 1999 Sep; 93(9):603-12. PubMed ID: 10542973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of mometasone furoate administered via a dry powder inhaler once daily in the evening on nocturnal lung function and sleep parameters in patients with moderate persistent asthma: a randomized, double-blind, placebo-controlled pilot study.
    Krouse JH; Krouse HJ; Janisse JJ
    Clin Drug Investig; 2009; 29(1):51-8. PubMed ID: 19067474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma.
    Karpel JP; Nelson H
    Curr Med Res Opin; 2007 Nov; 23(11):2897-911. PubMed ID: 17922978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of dry powder fluticasone propionate in children with persistent asthma.
    LaForce CF; Pearlman DS; Ruff ME; Silvers WS; Weinstein SW; Clements DS; Brown A; Duke S; Harding SM; House KW
    Ann Allergy Asthma Immunol; 2000 Nov; 85(5):407-15. PubMed ID: 11101186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids.
    Shapiro GG; Mendelson LM; Pearlman DS
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):633-40. PubMed ID: 11428735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma.
    Banov CH; Howland WC; Lumry WR
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):627-32. PubMed ID: 11428734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.
    Mandl M; Nolop K; Lutsky BN
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):237-45. PubMed ID: 9305231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative clinical study of inhaled beclomethasone dipropionate and triamcinolone acetonide in persistent asthma.
    Bronsky E; Korenblat P; Harris AG; Chen R
    Ann Allergy Asthma Immunol; 1998 Apr; 80(4):295-302. PubMed ID: 9564977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler.
    Bousquet J; D'Urzo A; Hebert J; Barraza CH; Boulet LP; Suárez-Chacón R; Harnest U; Lundbäck B; Martinez Morales G; Nieminen MM; Nolop KB; Visser S; Lutsky BN
    Eur Respir J; 2000 Nov; 16(5):808-16. PubMed ID: 11153576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
    Kuna P; Creemers JP; Vondra V; Black PN; Lindqvist A; Nihlen U; Vogelmeier C
    Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mometasone furoate: an effective anti-inflammatory with a well-defined safety and tolerability profile in the treatment of asthma.
    Bousquet J
    Int J Clin Pract; 2009 May; 63(5):806-19. PubMed ID: 19392928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate.
    Rojas RA; Paluga I; Goldfrad CH; Duggan MT; Barnes N
    J Asthma; 2007; 44(6):437-41. PubMed ID: 17654129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchodilation with mometasone furoate/formoterol fumarate administered by metered-dose inhaler with and without a spacer in children with persistent asthma.
    Berger WE; Bensch GW; Weinstein SF; Skoner DP; Prenner BM; Shekar T; Nolte H; Teper AA
    Pediatr Pulmonol; 2014 May; 49(5):441-50. PubMed ID: 24019197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction in oral corticosteroid use with mometasone furoate dry powder inhaler improves health-related quality of life in patients with severe persistent asthma.
    Schmier J; Leidy NK; Gower R
    J Asthma; 2003 Jun; 40(4):383-93. PubMed ID: 12870834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.